Literature DB >> 27049307

Overexpression of Dyrk1A regulates cardiac troponin T splicing in cells and mice.

Shu Lu1, Xiaomin Yin2.   

Abstract

The human heart expresses four isoforms of cardiac troponin T (cTnT) through alternative splicing of exons 4 and 5 of the cTnT gene. Alternative splicing of cTnT exon 5 is developmentally regulated. cTnT isoforms containing exon 5 are expressed in the fetal and neonatal heart but not in the mature heart. SRp55 is an essential splicing factor involved in cTnT exon 5 splicing and it is phosphorylated by Dyrk1A (dual specificity tyrosine phosphorylation regulated kinase 1A). In the present study, we found Dyrk1A interacted with SRp55 and enhanced its promotion of cTnT exon 5 inclusion. The shift from cTnT exon 5 inclusion to exclusion during development was delayed in the heart of Ts65Dn mice due to Dyrk1A overexpression. These results provide new insight into the role of Dyrk1A in the neonatal cardiac development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Cardiac troponin T; Dyrk1A; Exon 5

Mesh:

Substances:

Year:  2016        PMID: 27049307     DOI: 10.1016/j.bbrc.2016.04.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Javier G Blanco
Journal:  Exp Mol Pathol       Date:  2019-06-12       Impact factor: 3.362

Review 2.  Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond.

Authors:  Florentin Pastor; Lulzim Shkreta; Benoit Chabot; David Durantel; Anna Salvetti
Journal:  Front Microbiol       Date:  2021-03-29       Impact factor: 5.640

Review 3.  New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease.

Authors:  Leslye Venegas-Zamora; Francisco Bravo-Acuña; Francisco Sigcho; Wileidy Gomez; José Bustamante-Salazar; Zully Pedrozo; Valentina Parra
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

4.  Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes.

Authors:  Romina Beatriz Cejas; Miriam Tamaño-Blanco; John Edgar Fontecha; Javier Guillermo Blanco
Journal:  Cardiovasc Toxicol       Date:  2022-05-21       Impact factor: 2.755

Review 5.  mRNA Metabolism in Cardiac Development and Disease: Life After Transcription.

Authors:  Chen Gao; Yibin Wang
Journal:  Physiol Rev       Date:  2019-11-21       Impact factor: 37.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.